Showing 1 - 3 results of 3 for search 'Heidi Øyen Flemmen', query time: 0.02s Refine Results
  1. 1
    Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population

    Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population by Cecilia Smith Simonsen, Heidi Øyen Flemmen, Heidi Øyen Flemmen, Line Broch, Line Broch, Line Broch, Kamilla Brekke, Kamilla Brekke, Cathrine Brunborg, Pål Berg-Hansen, Elisabeth Gulowsen Celius, Elisabeth Gulowsen Celius

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

    Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry by Cecilia Smith Simonsen, Cecilia Smith Simonsen, Cecilia Smith Simonsen, Heidi Øyen Flemmen, Heidi Øyen Flemmen, Line Broch, Line Broch, Line Broch, Cathrine Brunborg, Pål Berg-Hansen, Stine Marit Moen, Elisabeth Gulowsen Celius, Elisabeth Gulowsen Celius

    Published 2021-06-01
    Get full text
    Article
  3. 3
    Patient‐reported outcome after treatment for definite Lyme neuroborreliosis

    Patient‐reported outcome after treatment for definite Lyme neuroborreliosis by Randi Eikeland, Unn Ljøstad, Geir Helgeland, Geir Sand, Heidi Øyen Flemmen, Margrete Halvorsen Bø, Ludmila Nordaa, Jone Furulund Owe, Åse Mygland, Åslaug Rudjord Lorentzen

    Published 2020-04-01
    Get full text
    Article

Search Tools: